Qingdao NovelBeam Technology Co. Ltd. A (688677) - Net Assets
Based on the latest financial reports, Qingdao NovelBeam Technology Co. Ltd. A (688677) has net assets worth CN¥1.26 Billion CNY (≈ $184.29 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.51 Billion ≈ $221.37 Million USD) and total liabilities (CN¥253.36 Million ≈ $37.07 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Qingdao NovelBeam Technology Co. Ltd. A asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.26 Billion |
| % of Total Assets | 83.25% |
| Annual Growth Rate | 31.69% |
| 5-Year Change | 308.35% |
| 10-Year Change | 1277.53% |
| Growth Volatility | 65.86 |
Qingdao NovelBeam Technology Co. Ltd. A - Net Assets Trend (2013–2024)
This chart illustrates how Qingdao NovelBeam Technology Co. Ltd. A's net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of Qingdao NovelBeam Technology Co. Ltd. A for the complete picture of this company's asset base.
Annual Net Assets for Qingdao NovelBeam Technology Co. Ltd. A (2013–2024)
The table below shows the annual net assets of Qingdao NovelBeam Technology Co. Ltd. A from 2013 to 2024. For live valuation and market cap data, see 688677 stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.31 Billion ≈ $191.03 Million |
+0.98% |
| 2023-12-31 | CN¥1.29 Billion ≈ $189.17 Million |
+5.75% |
| 2022-12-31 | CN¥1.22 Billion ≈ $178.89 Million |
+11.67% |
| 2021-12-31 | CN¥1.09 Billion ≈ $160.20 Million |
+242.44% |
| 2020-12-31 | CN¥319.69 Million ≈ $46.78 Million |
+42.21% |
| 2019-12-31 | CN¥224.80 Million ≈ $32.90 Million |
-2.03% |
| 2018-12-31 | CN¥229.45 Million ≈ $33.58 Million |
+18.47% |
| 2017-12-31 | CN¥193.68 Million ≈ $28.34 Million |
+36.19% |
| 2016-12-31 | CN¥142.21 Million ≈ $20.81 Million |
+50.06% |
| 2015-12-31 | CN¥94.77 Million ≈ $13.87 Million |
+36.09% |
| 2014-12-31 | CN¥69.64 Million ≈ $10.19 Million |
+10.20% |
| 2013-12-31 | CN¥63.19 Million ≈ $9.25 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Qingdao NovelBeam Technology Co. Ltd. A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 3138.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥577.07 Million | 44.27% |
| Common Stock | CN¥120.61 Million | 9.25% |
| Other Comprehensive Income | CN¥3.15 Million | 0.24% |
| Other Components | CN¥602.66 Million | 46.23% |
| Total Equity | CN¥1.30 Billion | 100.00% |
Qingdao NovelBeam Technology Co. Ltd. A Competitors by Market Cap
The table below lists competitors of Qingdao NovelBeam Technology Co. Ltd. A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hugo Boss AG
F:BOSA
|
$2.45 Billion |
|
Zhejiang Huace Film TV Co
SHE:300133
|
$2.45 Billion |
|
Liberty Live Holdings, Inc. Series A Liberty Live Group Common Stock
NASDAQ:LLYVA
|
$2.45 Billion |
|
Sinofibers Technology Co Ltd
SHE:300777
|
$2.45 Billion |
|
Sai Gon Ha Noi Commercial Joint Stock Bank
VN:SHB
|
$2.45 Billion |
|
BREVILLE GROUP LTD
F:HDE
|
$2.45 Billion |
|
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
|
$2.45 Billion |
|
Hangzhou Robam Appliances Co Ltd
SHE:002508
|
$2.45 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Qingdao NovelBeam Technology Co. Ltd. A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,292,584,352 to 1,303,492,801, a change of 10,908,449 (0.8%).
- Net income of 135,348,545 contributed positively to equity growth.
- Dividend payments of 66,747,311 reduced retained earnings.
- Share repurchases of 47,654,888 reduced equity.
- Other comprehensive income decreased equity by 43,521,880.
- Other factors increased equity by 33,483,983.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥135.35 Million | +10.38% |
| Dividends Paid | CN¥66.75 Million | -5.12% |
| Share Repurchases | CN¥47.65 Million | -3.66% |
| Other Comprehensive Income | CN¥-43.52 Million | -3.34% |
| Other Changes | CN¥33.48 Million | +2.57% |
| Total Change | CN¥- | 0.84% |
Book Value vs Market Value Analysis
This analysis compares Qingdao NovelBeam Technology Co. Ltd. A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 12.94x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 69.76x to 12.94x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | CN¥2.00 | CN¥139.57 | x |
| 2014-12-31 | CN¥2.21 | CN¥139.57 | x |
| 2015-12-31 | CN¥2.93 | CN¥139.57 | x |
| 2016-12-31 | CN¥4.30 | CN¥139.57 | x |
| 2017-12-31 | CN¥4.65 | CN¥139.57 | x |
| 2018-12-31 | CN¥2.32 | CN¥139.57 | x |
| 2019-12-31 | CN¥1.81 | CN¥139.57 | x |
| 2020-12-31 | CN¥4.35 | CN¥139.57 | x |
| 2021-12-31 | CN¥12.50 | CN¥139.57 | x |
| 2022-12-31 | CN¥10.02 | CN¥139.57 | x |
| 2023-12-31 | CN¥10.64 | CN¥139.57 | x |
| 2024-12-31 | CN¥10.79 | CN¥139.57 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Qingdao NovelBeam Technology Co. Ltd. A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.38%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 30.56%
- • Asset Turnover: 0.30x
- • Equity Multiplier: 1.12x
- Recent ROE (10.38%) is below the historical average (17.40%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | -1.48% | -1.79% | 0.36x | 2.31x | CN¥-7.24 Million |
| 2014 | 9.50% | 9.74% | 0.41x | 2.37x | CN¥-349.37K |
| 2015 | 16.40% | 21.08% | 0.39x | 1.98x | CN¥6.06 Million |
| 2016 | 23.04% | 23.49% | 0.66x | 1.49x | CN¥18.55 Million |
| 2017 | 26.33% | 28.22% | 0.78x | 1.19x | CN¥31.68 Million |
| 2018 | 24.36% | 27.18% | 0.74x | 1.22x | CN¥32.16 Million |
| 2019 | 32.67% | 28.45% | 0.77x | 1.50x | CN¥49.92 Million |
| 2020 | 30.55% | 35.01% | 0.66x | 1.32x | CN¥64.81 Million |
| 2021 | 10.79% | 38.02% | 0.26x | 1.08x | CN¥8.63 Million |
| 2022 | 14.97% | 38.29% | 0.34x | 1.14x | CN¥60.65 Million |
| 2023 | 11.27% | 30.96% | 0.34x | 1.08x | CN¥16.45 Million |
| 2024 | 10.38% | 30.56% | 0.30x | 1.12x | CN¥5.00 Million |
Industry Comparison
This section compares Qingdao NovelBeam Technology Co. Ltd. A's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $3,713,385,755
- Average return on equity (ROE) among peers: 16.21%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Qingdao NovelBeam Technology Co. Ltd. A (688677) | CN¥1.26 Billion | -1.48% | 0.20x | $2.45 Billion |
| Beijing Centergate Technologies Holding Co Ltd (000931) | $659.01 Million | 0.64% | 5.75x | $472.78 Million |
| Blue Sail Medical Co Ltd (002382) | $9.82 Billion | 17.91% | 0.74x | $1.02 Billion |
| Andon Health Co Ltd (002432) | $21.49 Billion | 7.76% | 0.23x | $6.23 Billion |
| Allmed Medical Products Co Ltd Class A (002950) | $3.13 Billion | 12.99% | 0.84x | $975.78 Million |
| Guangzhou Improve Med Instrument (300030) | $762.33 Million | -8.29% | 0.87x | $328.02 Million |
| QITIAN Technology Group Co Ltd (300061) | $369.27 Million | 4.34% | 0.26x | $1.11 Billion |
| Shanghai Tofflon Science Tech (300171) | $331.97 Million | 43.03% | 1.51x | $1.35 Billion |
| Truking Technology Ltd (300358) | $31.38 Million | 49.25% | 3.63x | $919.79 Million |
| Jiangxi Sanxin Medtec Co Ltd (300453) | $250.27 Million | 19.43% | 0.52x | $725.77 Million |
| Shenyang Xingqi Pharmaceutical Co Ltd (300573) | $290.70 Million | 15.03% | 0.44x | $1.51 Billion |
About Qingdao NovelBeam Technology Co. Ltd. A
Qingdao NovelBeam Technology Co.,Ltd. engages in the research, development, production, and sales of medical endoscopic instruments and optical products worldwide. The company offers medical device products and components, such as endoscopes, light sources, and camera systems for surgical operations, as well as surgical external vision system, endoscope system, and other complete systems; and opt… Read more